Evidence map›Paper›PMID 27156644›Full record

ArticleJournal of pharmaceutical and biomedical analysis2016

Ligand fishing using new chitosan based functionalized Androgen Receptor magnetic particles.

Michał Piotr Marszałł, Wiktor Dariusz Sroka, Adam Sikora, Dorota Chełminiak, Marta Ziegler-Borowska, Tomasz Siódmiak, Ruin Moaddel

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmaceutical and biomedical analysis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Effect of Aminated Chitosan-Coated FeInternational journal of molecular sciences · 2021
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Michał Piotr MarszałłNicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Department of Medicinal Chemistry, ul. Jurasza 2, 85-089 Bydgoszcz, Poland. Electronic address: mmars@cm.umk.pl.
Wiktor Dariusz SrokaNicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Department of Medicinal Chemistry, ul. Jurasza 2, 85-089 Bydgoszcz, Poland.
Adam SikoraNicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Department of Medicinal Chemistry, ul. Jurasza 2, 85-089 Bydgoszcz, Poland.
Dorota ChełminiakNicolaus Copernicus University in Torun, Faculty of Chemistry Gagarina 7, 87-100 Torun, Poland.
Marta Ziegler-BorowskaNicolaus Copernicus University in Torun, Faculty of Chemistry Gagarina 7, 87-100 Torun, Poland.
Tomasz SiódmiakNicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Department of Medicinal Chemistry, ul. Jurasza 2, 85-089 Bydgoszcz, Poland.
Ruin MoaddelLaboratory of Clinical Investigation, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Nicolaus Copernicus University · PLCollegium Medicum in Bydgoszcz · PLInstitute on Aging · US

Funding

Immobilized Receptors In Drug DiscoveryZIAAG000295 · NIA · NATIONAL INSTITUTE ON AGING · PI EGAN, JOSEPHINE · 2009 to 2025
$11.4M
Intramural NIH HHS Z99 AG999999Intramural NIH HHS ZIA AG000295
6 · The paper itself

Abstract

Superparamagnetic nanoparticles with chemically modified chitosan has been proposed as a potential support for the immobilization of the androgen receptor (AR). The study involved comparison of different AR carriers like commercially available magnetic beads coated with silica (BcMag) and chitosan coated nanoparticles with different amount of amino groups. The immobilization was carried out through covalent immobilization of the AR through the terminal amino group or through available carboxylic acids. The initial characterization of the AR coated magnetic beads was carried out with dihydrotestosterone, a known AR ligand. Subsequently, chitosan modified nanporticles with long-distanced primary amino groups (Fe3O4CS-(NH2)3) (upto 8.34mM/g) were used for further study to isolate known AR ligands (bicalutamide, flutamide, hydroxyflutamide and levonogestrel) from a mixture of tested compounds in ammonium acetate buffer [10mM, pH 7.4]. The results showed that the selected nanoparticles are a promising semi-quantitative tool for the identification of high affinity compounds to AR and might be of special importance in the identification of novel agonists or antiandrogens.

Indexed as

Androgen AntagonistsChitosanDrug DiscoveryImmobilized ProteinsLigandsMagnetite NanoparticlesProtein BindingReceptors, AndrogenSurface PropertiesAndrogen AntagonistsChitosanImmobilized ProteinsLigandsMagnetite NanoparticlesReceptors, AndrogenAndrogen receptorAntiandrogensChitosanLigand fishingMagnetic beads

Identifiers

PMID27156644
PMCPMC5004595
OpenAlexW2345661503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.